Jazz Pharmaceuticals Form 144: 6,000-Share Notice

Jazz Pharmaceuticals proposed sale notice (Form 144): A notice lists a proposed sale of 6,000 shares of Common Stock with a transaction date shown as 04/01/2026 and Nasdaq as the market.

Accepted by SEC EDGAR 04/01/2026 - 04:03 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Jazz Pharmaceuticals proposed sale notice (Form 144): A notice lists a proposed sale of 6,000 shares of Common Stock with a transaction date shown as 04/01/2026 and Nasdaq as the market. The filing also records a prior sale of 6,000 shares on 03/03/2026 for $1,118,613.32.

Key Figures

Proposed shares to be sold: 6,000 shares Prior sale shares: 6,000 shares Proceeds from prior sale: $1,118,613.32 +3 more

6 metrics

Proposed shares to be sold 6,000 shares listed with date <date>04/01/2026</date> and market NASDAQ

Prior sale shares 6,000 shares sold on <date>03/03/2026</date>

Proceeds from prior sale $1,118,613.32 proceeds for 6,000 shares on <date>03/03/2026</date>

Option quantity (1) 1,344 Stock Option dated <date>01/03/2022</date>

Option quantity (2) 3,909 Stock Option dated <date>01/03/2022</date>

Option quantity (3) 747 Stock Option dated <date>02/01/2022</date>

Key Terms

Form 144, Stock Option, Common, Proceeds

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option financial

"Stock Option | Jazz Pharmaceuticals PLC | | | 1344"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Common financial

"Common | Merrill Lynch 3075A Hansen Way 1st Floor Palo Alto CA 94304 | 6000"

Proceeds financial

"6000 | 1118613.32"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Jazz Pharmaceuticals' Form 144 (JAZZ) show?

The Form 144 lists a proposed sale of 6,000 shares of Common Stock with a market noted as Nasdaq. It also records a prior sale of 6,000 shares on 03/03/2026 for $1,118,613.32.

Who is the reporting party on the JAZZ Form 144?

The filing names Bruce Cozadd with an address in Dublin as the reporting person. The document links his name to the recorded sale of 6,000 shares on 03/03/2026 for $1,118,613.32.

Which securities and quantities are listed on the JAZZ filing?

The filing lists Common Stock and several stock-option‑derived quantities: 1,344, 3,909, and 747 (each tied to option grant dates). It also shows a proposed/common sale of 6,000 shares associated with Nasdaq.

What price or proceeds are disclosed in the JAZZ Form 144?

A prior sale entry shows proceeds of $1,118,613.32 for 6,000 shares on 03/03/2026. No explicit per-share price for the proposed 6,000-share sale is provided in the excerpt.

Does the JAZZ Form 144 show how the securities were acquired?

Yes. The excerpt lists acquisition types as Stock Option with grant dates 01/03/2022 and 02/01/2022. Specific option exercise prices are not shown in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001193210
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Jazz Pharmaceuticals Plc
SEC File Number	001-33500
Address of Issuer	5th Floor Waterloo Exchange Waterloo Road Dublin IRELAND D04 E5W7
Phone	353-1-634-7800
Name of Person for Whose Account the Securities are To Be Sold	Bruce C Cozadd
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 3075A Hansen Way 1st Floor Palo Alto CA 94304	6000	1143010.3	61560350	04/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/03/2022	Stock Option	Jazz Pharmaceuticals PLC			1344	01/03/2022	Cash
Common	01/03/2022	Stock Option	Jazz Pharmaceuticals PLC			3909	01/03/2022	Cash
Common	02/01/2022	Stock Option	Jazz Pharmaceuticals PLC			747	02/01/2022	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Bruce Cozadd 5th Floor Waterloo Exchange Waterloo Road Dublin L2 D04-E5W7	Common	03/03/2026	6000	1118613.32

144: Remarks and Signature

Remarks
Date of Notice	04/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Bruce C Cozadd
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)